QLGN News and Press, Qualigen Therapeutics Inc. From 04/12/21

iRhythm Technologies (IRTC) -30% after Novitas publishes updated reimbursement rates.Qualigen Therapeutics (QLGN) -18% after it pulls marketing application for COVID-19 test.Gulf Resources (GURE) -11% on correcting and replacing - Q4 & FY2020 financial result...

Qualigen Therapeutics (QLGN) has announced that it has withdrawn the emergency use authorization application submitted to the FDA for FastPack COVID-19 diagnostic test. In reaction, the shares have dropped ~16.5% in post-market trading.Since the market application was submitted...

Innovation, R&D and an aging population are long-term secular trends that will provide a tailwind to the biotechnology sector. The Insurgent AI Deep Innovation Model uses Deep Learning and secular tailwinds to generate alpha. Evaluating investment strategies is challenging, es...

The following slide deck was published by Qualigen Therapeutics, Inc. in conjunction with this event. For further details see: Qualigen Therapeutics (QLGN) Investor Presentation - Slideshow

CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that Michael Poirier, President, Chief Executive Officer and Chai...

CARLSBAD, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, announced today that it has promoted long-time officer Shishir Sinha to the ...

CARLSBAD, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that Michael Poirier, President, Chief Executive Officer and Chai...

CARLSBAD, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) , a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today it has entered into a Material Evaluation and Option Agreeme...

4 Penny Stocks To Watch With Increased Volume This Month Penny stocks were in direct focus on Wednesday. Partially thanks to surging prices in names like Express and GameStop, traders were seeking volatility. It was also a topic of conversation on countless financial outlets (obviou...

Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China PR Newswire CARLSBAD, Calif. , Jan. 26, 2021 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN),...